A Prospective, Non-randomized Study to Evaluate the Safety and Performance of the NovaCross™ Microcatheter in Femoropopliteal Chronic Total Occlusion (CTO).
NCT02358629
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
14
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Total Occlusion
Interventions
DEVICE:
NovaCross™ microcatheter
Sponsor
Nitiloop Ltd.